Evaluation of Educational Interventions Targeting Beliefs About Human Papillomavirus (HPV)

August 27, 2024 updated by: Selva Dilan Golbasi Koc, Eskisehir Osmangazi University

Evaluation of Educational Interventions Targeting Beliefs About Human Papillomavirus (HPV) Among Female Employees

The goal of this clinical trial is to compare the effects of two different educational training programs on beliefs about Human Papillomavirus (HPV) in a group of female hospital employees. The main questions it aims to answer are: • Within the scope of the study, are the training programs provided to reduce misconceptions about HPV effective? • Which educational program is more effective in reducing misconceptions about HPV? Participants will • Complete a pre-test online the day before the first training date to determine the level of their misconceptions about HPV. • Receive informative messages via Whatsapp once a day for three days according to the training program they are assigned to. • Repeat the pre-test at the end of the training programs and one month later. • Receive the more effective training program after one month after the test repetition for the control group. Researchers will compare "Misbeliefs about HPV" and "Current Knowledge about HPV" titled training programs on reducing misconceptions about HPV.

Study Overview

Status

Enrolling by invitation

Conditions

Intervention / Treatment

Detailed Description

The human papillomavirus (HPV) can cause health problems ranging from warts in the mouth or genital area to cervical, vaginal, vulvar, penile and anal cancers. Some beliefs about diseases or infectious agents have a negative impact on the early diagnosis and treatment of diseases, particularly by increasing the stigmatization effect of sexually transmitted diseases. Features such as the fact that mucosal contact is sufficient for transmission, that infected people can be symptom-free for a long time, that cancer often develops slowly, and that there are similarities with other sexually transmitted viruses such as HIV (human immunodeficiency virus) or herpes can have a negative impact on knowledge and beliefs about HPV.

It is known that it is crucial to emphasize correct information, not to repeat or point out inaccuracies when taking action to combat false beliefs or myths. In the context of the COVID-19 pandemic, the importance of this approach has been frequently emphasized in the guidance contained in the confirmatory information on misinformation and disinformation. In our study, we want to compare the effectiveness of education models in which false beliefs or myths about HPV are conveyed before or after the current information.

Study Type

Interventional

Enrollment (Estimated)

102

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey
    • Eskisehir
      • Odunpazarı, Eskisehir, Turkey, 26040
        • Eskisehir Osmangazi University Public Health Department

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Woman
  • Age >18 years and older
  • Those who agree to participate in the study

Exclusion Criteria:

  • Age <18 years
  • Those who not agree to participate in the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Training for HPV misbeliefs 1
Participants will receive misbeliefs about HPV; training where misbeliefs are mentioned before the current information.
Behavioral: Misbeliefs about HPV training
Intervention trainings mentioned false beliefs before or after the current knowledge
Experimental: Training for HPV misbeliefs 2
Participants will receive misbeliefs about HPV; training where misbeliefs are mentioned after the current information.
Behavioral: Misbeliefs about HPV training
Intervention trainings mentioned false beliefs before or after the current knowledge

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Health Beliefs about Human Papillomavirus (HPV)
Time Frame: From enrollment to the end of intervention at 4 weeks
Measuring with: "False Beliefs About HPV Scale"
From enrollment to the end of intervention at 4 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Eskisehir Osmangazi University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 29, 2024

Primary Completion (Estimated)

October 1, 2024

Study Completion (Estimated)

December 1, 2024

Study Registration Dates

First Submitted

December 25, 2023

First Submitted That Met QC Criteria

January 9, 2024

First Posted (Actual)

January 10, 2024

Study Record Updates

Last Update Posted (Actual)

August 28, 2024

Last Update Submitted That Met QC Criteria

August 27, 2024

Last Verified

August 1, 2024

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • E-80558721-050.99-413737

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Data obtained through this study may be provided to qualified researchers with academic interest in beliefs about Human Papillomavirus. Data or samples shared will be coded, with no PHI included. Approval of the request and execution of all applicable agreements are prerequisites to the sharing of data with the requesting party.

IPD Sharing Time Frame

As of March 2024

IPD Sharing Access Criteria

"Access to trial IPD can be requested by qualified researchers engaging in independent scientific research and will be provided following review and approval of a research proposal and Statistical Analysis Plan (SAP) and execution of a Data Sharing Agreement (DSA). For more information or to submit a request, please contact selvadilangolbasi@gmail.com"

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ICF
  • ANALYTIC_CODE
  • CSR

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on HPV

Clinical Trials on Misbeliefs about HPV training

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Canada

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe